BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17410555)

  • 1. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals.
    Srebalus Barnes CA; Lim A
    Mass Spectrom Rev; 2007; 26(3):370-88. PubMed ID: 17410555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoproteomics by mass spectrometry and classical protein chemistry approaches.
    Salih E
    Mass Spectrom Rev; 2005; 24(6):828-46. PubMed ID: 15538747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of peptide mapping with electrospray mass spectrometry for recombinant proteins of biopharmaceutical interest and its applications as an identity test and a characterization tool.
    Wei Z; Tous G; Yim A; Hope JN; Casas-Finet JR; Folena-Wasserman G; Schenerman MA
    Dev Biol (Basel); 2005; 122():29-47. PubMed ID: 16375249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry for structural characterization of therapeutic antibodies.
    Zhang Z; Pan H; Chen X
    Mass Spectrom Rev; 2009; 28(1):147-76. PubMed ID: 18720354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of LC/MS in structure identifications of small molecules and proteins in drug discovery.
    Chen G; Pramanik BN; Liu YH; Mirza UA
    J Mass Spectrom; 2007 Mar; 42(3):279-87. PubMed ID: 17295416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.
    Reid CQ; Tait A; Baldascini H; Mohindra A; Racher A; Bilsborough S; Smales CM; Hoare M
    Biotechnol Bioeng; 2010 Sep; 107(1):85-95. PubMed ID: 20506289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron capture dissociation mass spectrometry in characterization of peptides and proteins.
    Bakhtiar R; Guan Z
    Biotechnol Lett; 2006 Jul; 28(14):1047-59. PubMed ID: 16794768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry.
    Xie H; Gilar M; Gebler JC
    Anal Chem; 2009 Jul; 81(14):5699-708. PubMed ID: 19518054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of post-translational modifications by blind search of mass spectra.
    Tsur D; Tanner S; Zandi E; Bafna V; Pevzner PA
    Nat Biotechnol; 2005 Dec; 23(12):1562-7. PubMed ID: 16311586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric analysis of innovator, counterfeit, and follow-on recombinant human growth hormone.
    Jiang H; Wu SL; Karger BL; Hancock WS
    Biotechnol Prog; 2009; 25(1):207-18. PubMed ID: 19224592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine sensitive peptide mapping using LC/MS of therapeutic proteins produced by recombinant DNA technology.
    Mock K
    Pept Res; 1993; 6(2):100-4. PubMed ID: 8485338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein sequence information by matrix-assisted laser desorption/ionization in-source decay mass spectrometry.
    Hardouin J
    Mass Spectrom Rev; 2007; 26(5):672-82. PubMed ID: 17492750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS for protein characterization: current capabilities and future trends.
    Chen G; Pramanik BN
    Expert Rev Proteomics; 2008 Jun; 5(3):435-44. PubMed ID: 18532911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary mass spectrometric techniques to achieve complete sequence coverage of recombinant human tropoelastin.
    Getie M; Schmelzer CE; Weiss AS; Neubert RH
    Rapid Commun Mass Spectrom; 2005; 19(20):2989-93. PubMed ID: 16178053
    [No Abstract]   [Full Text] [Related]  

  • 15. Automated mass correction and data interpretation for protein open-access liquid chromatography-mass spectrometry.
    Wagner CD; Hall JT; White WL; Miller LA; Williams JD
    J Mass Spectrom; 2007 Feb; 42(2):139-49. PubMed ID: 17221927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and localization of protein modifications by high resolution tandem mass spectrometry.
    Meng F; Forbes AJ; Miller LM; Kelleher NL
    Mass Spectrom Rev; 2005; 24(2):126-34. PubMed ID: 15389861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of protein mass spectrometry in cell biology.
    Rowley A; Choudhary JS; Marzioch M; Ward MA; Weir M; Solari RC; Blackstock WP
    Methods; 2000 Apr; 20(4):383-97. PubMed ID: 10720459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characterization of protein post-translational modifications by mass spectrometry.
    Schweppe RE; Haydon CE; Lewis TS; Resing KA; Ahn NG
    Acc Chem Res; 2003 Jun; 36(6):453-61. PubMed ID: 12809532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of IgG1 immunoglobulins and peptide-Fc fusion proteins by limited proteolysis in conjunction with LC-MS.
    Kleemann GR; Beierle J; Nichols AC; Dillon TM; Pipes GD; Bondarenko PV
    Anal Chem; 2008 Mar; 80(6):2001-9. PubMed ID: 18293943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. swissPIT: a novel approach for pipelined analysis of mass spectrometry data.
    Quandt A; Hernandez P; Masselot A; Hernandez C; Maffioletti S; Pautasso C; Appel RD; Lisacek F
    Bioinformatics; 2008 Jun; 24(11):1416-7. PubMed ID: 18436540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.